Paper37568616
Clinical Significance of Early Venous Filling Detected via Preoperative Angiography in Glioblastoma.
Tatebayashi K and 10 others. Cancers (Basel), 2023. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Clinical Significance of Early Venous Filling Detected via Preoperative Angiography in Glioblastoma. Papers, record 37568616. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37568616
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinical Significance of Early Venous Filling Detected via Preoperative Angiography in Glioblastoma.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| none | Hyogo Medical University Grant for Research Promotion, 2022. | PubMed |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32359215 | Association between glioblastoma cell-derived vessels and poor prognosis of the patients. | Cancer Commun (Lond) | 2020 | https://conductscience.org/library/papers/32359215 | PubMed |
| 2 | 26899730 | Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis. | Angiogenesis | 2016 | https://conductscience.org/library/papers/26899730 | PubMed |
| 3 | 34967558 | Diagnostic Accuracy of Immunohistochemistry in Detecting MGMT Methylation Status in Patients with Glioma. | Asian Pac J Cancer Prev | 2021 | https://conductscience.org/library/papers/34967558 | PubMed |
| 4 | 15758010 | MGMT gene silencing and benefit from temozolomide in glioblastoma. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15758010 | PubMed |
| 5 | 26453565 | Anatomical specificity of vascular endothelial growth factor expression in glioblastomas: a voxel-based mapping analysis. | Neuroradiology | 2016 | https://conductscience.org/library/papers/26453565 | PubMed |
| 6 | 14976322 | Appearance of early venous filling during intra-arterial reperfusion therapy for acute middle cerebral artery occlusion: a predictive sign for hemorrhagic complications. | Stroke | 2004 | https://conductscience.org/library/papers/14976322 | PubMed |
| 7 | 10487832 | Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. | Am J Pathol | 1999 | https://conductscience.org/library/papers/10487832 | PubMed |
| 8 | 33472628 | The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment. | Cancer Cell Int | 2021 | https://conductscience.org/library/papers/33472628 | PubMed |
| 9 | 11220379 | Intratumoral arteriovenous shunting in malignant gliomas. | Neurosurgery | 2001 | https://conductscience.org/library/papers/11220379 | PubMed |
| 10 | 33465401 | Vasculogenic mimicry, a complex and devious process favoring tumorigenesis - Interest in making it a therapeutic target. | Pharmacol Ther | 2021 | https://conductscience.org/library/papers/33465401 | PubMed |
| 11 | 20631803 | The shunt problem: control of functional shunting in normal and tumour vasculature. | Nat Rev Cancer | 2010 | https://conductscience.org/library/papers/20631803 | PubMed |
| 12 | 20888136 | Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma. | Int J Radiat Oncol Biol Phys | 2011 | https://conductscience.org/library/papers/20888136 | PubMed |
| 13 | 31713017 | Delay in diagnosing patients with right-sided glioblastoma induced by hemispheric-specific clinical presentation. | J Neurooncol | 2020 | https://conductscience.org/library/papers/31713017 | PubMed |
| 14 | 5642293 | Early venous filling in cranial angiography. | Radiology | 1968 | https://conductscience.org/library/papers/5642293 | PubMed |
| 15 | 11559541 | Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. | Cancer Res | 2001 | https://conductscience.org/library/papers/11559541 | PubMed |
| 16 | 26847813 | Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial. | J Neurooncol | 2016 | https://conductscience.org/library/papers/26847813 | PubMed |
| 17 | 34803608 | Non-Coding RNAs in Glioma Microenvironment and Angiogenesis. | Front Mol Neurosci | 2021 | https://conductscience.org/library/papers/34803608 | PubMed |
| 18 | 24552317 | A randomized trial of bevacizumab for newly diagnosed glioblastoma. | N Engl J Med | 2014 | https://conductscience.org/library/papers/24552317 | PubMed |
| 19 | 34359588 | Recent Advances in Glioma Therapy: Combining Vascular Normalization and Immune Checkpoint Blockade. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34359588 | PubMed |
| 20 | 27756883 | Bevacizumab and wound-healing complications: a systematic review and meta-analysis of randomized controlled trials. | Oncotarget | 2016 | https://conductscience.org/library/papers/27756883 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 38275409 | CRISPR/Cas9-Mediated Gene Therapy for Glioblastoma: A Scoping Review. | Biomedicines | 2024 | https://conductscience.org/library/papers/38275409 |
Source PubMed
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD34 | 947 | PubTator's text mining | https://conductscience.org/library/genes/947 | NCBI Gene |
| HIF1A | 3091 | PubTator's text mining | https://conductscience.org/library/genes/3091 | NCBI Gene |
| IDH1 | 3417 | PubTator's text mining | https://conductscience.org/library/genes/3417 | NCBI Gene |
| MGMT | 4255 | PubTator's text mining | https://conductscience.org/library/genes/4255 | NCBI Gene |
| MIB1 | 57534 | PubTator's text mining | https://conductscience.org/library/genes/57534 | NCBI Gene |
| PECAM1 | 5175 | PubTator's text mining | https://conductscience.org/library/genes/5175 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37568616
GET https://conductscience.org/api/papers/v1/37568616/references?page=2